References
Anaissie E, Paetznick V, Bodey GF Fluconazole susceptibility testing toCandida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading. Antimicrobial Agents and Chemotherapy 1991, 35: 1641–1646.
Dupouy-Camet J, Paugam A, Di Donato C, Viguie C, Vicens I, Volle PJ, Tourte-Schaefer C Resistance au fluoconazole en milieu hospitalier. Concordance entre la resistance deCandida albicans in vitro et l'echec therapeutique. La Presse Médicale 1991, 20: 1341.
Dupouy-Camet J, Paugam A, Tourte-Schaefer C Yeast susceptibility testing. Lancet 1991, 338: 383.
Akova M, Akalin HE, Uzun Ö, Gür D Emergence ofCandida krusei infections after therapy of oropharyngeal candidiasis with fluconazole. European Journal of Clinical Microbiology & Infectious Diseases 1991, 10: 598–599.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scheven, M. Susceptibility of yeasts to fluconazole. Eur. J. Clin. Microbiol. Infect. Dis. 11, 870 (1992). https://doi.org/10.1007/BF01960894
Issue Date:
DOI: https://doi.org/10.1007/BF01960894